JNJ-67896062 clinical trials

A multicenter, open-label, randomized study with single-arm extension period to assess the pharmacokinetics, safety and efficacy of macitentan versus standard of care in children with pulmonary arterial hypertension

This study is looking at a new medicine called macitentan for children with a serious lung condition called pulmonary arterial hypertension (PAH). Researchers want to see how much of the medicine gets into the body, if it's safe, and if it helps children feel better compared to usual treatments.